Identification of candidate biomarker proteins released by human endometrial and cervical cancer cells using two-dimensional liquid chromatography/tandem mass spectrometry
- PMID: 17523614
- DOI: 10.1021/pr0700798
Identification of candidate biomarker proteins released by human endometrial and cervical cancer cells using two-dimensional liquid chromatography/tandem mass spectrometry
Abstract
Candidate biomarker proteins, including chaperonin 10 and pyruvate kinase, previously discovered and identified using mass-tagging reagents with multidimensional liquid chromatography and tandem mass spectrometry (DeSouza, L.; et al. J. Proteome Res. 2005, 4, 377-386) have been identified in serum-free media of cultured endometrial cancer (KLE and HEC-1-A) and cervical cancer (HeLa) cells. These and other cancer-associated proteins were released by the cultured cells within 24 h of growth. A total of 203 proteins from the KLE cells, 86 from HEC-1-A, and 161 from HeLa are reported.
Similar articles
-
Verification of endometrial tissue biomarkers previously discovered using mass spectrometry-based proteomics by means of immunohistochemistry in a tissue microarray format.J Proteome Res. 2007 Jul;6(7):2648-55. doi: 10.1021/pr070087o. Epub 2007 Jun 7. J Proteome Res. 2007. PMID: 17552551
-
Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer.Anal Chem. 2009 May 1;81(9):3462-70. doi: 10.1021/ac802726a. Anal Chem. 2009. PMID: 19323455
-
Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.J Proteome Res. 2008 May;7(5):2078-87. doi: 10.1021/pr7007797. Epub 2008 Apr 12. J Proteome Res. 2008. PMID: 18407684
-
Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.J Proteome Res. 2009 Jan;8(1):362-73. doi: 10.1021/pr800622b. J Proteome Res. 2009. PMID: 19053527
-
A proteomics study on human breast cancer cell lines by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry.Biomed Chromatogr. 2008 Nov;22(11):1304-14. doi: 10.1002/bmc.1102. Biomed Chromatogr. 2008. PMID: 18821527
Cited by
-
Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry.Mol Cell Proteomics. 2008 Jun;7(6):1162-73. doi: 10.1074/mcp.M700500-MCP200. Epub 2008 Mar 13. Mol Cell Proteomics. 2008. PMID: 18339795 Free PMC article.
-
Combining results from lectin affinity chromatography and glycocapture approaches substantially improves the coverage of the glycoproteome.Mol Cell Proteomics. 2009 Feb;8(2):287-301. doi: 10.1074/mcp.M800272-MCP200. Epub 2008 Oct 15. Mol Cell Proteomics. 2009. PMID: 18923192 Free PMC article.
-
HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines.Int J Mol Sci. 2013 Mar 15;14(3):6026-43. doi: 10.3390/ijms14036026. Int J Mol Sci. 2013. PMID: 23502467 Free PMC article.
-
GBM secretome induces transient transformation of human neural precursor cells.J Neurooncol. 2012 Sep;109(3):457-66. doi: 10.1007/s11060-012-0917-1. Epub 2012 Jul 1. J Neurooncol. 2012. PMID: 22752853
-
Identification of differentially regulated secretome components during skeletal myogenesis.Mol Cell Proteomics. 2011 May;10(5):M110.004804. doi: 10.1074/mcp.M110.004804. Epub 2011 Feb 22. Mol Cell Proteomics. 2011. PMID: 21343469 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical